Such tests are increasingly moving beyond their origins in cutting-edge research and into the laboratory and diagnostic ...

NfL was assessed using the ultrasensitive Simoa and microfluidic Ella platforms and with Lumipulse and Elecsys assays, ...

NfL was assessed using the ultrasensitive Simoa and microfluidic Ella platforms and with Lumipulse and Elecsys assays, ...

Simoa is a breakthrough in biomarker detection due to its extremely high sensitivity and specificity. This technology combines single-molecule immunocapture with fluorescence detection, capable of ...

The test utilized a single-molecule assay (Simoa) platform, employing monoclonal antibodies tau368 and CT23.1 for capture and detection, respectively. This assay measured both STA and total tau (t ...

Ready to expand the possibilities of biomarker science? The Simoa® Accelerator Laboratory is a full-service center for biopharmaceutical research. The Accelerator Lab provides exploratory protein ...

Our group studies neuroinflammation in multiple neurological conditions (e.g. Multiple Sclerosis, Autoimmune Encephalitis and Brain Cancer), with a focus on the role of innate immunity and purinergic ...